Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 3, 1999

View Archived Issues

Peptide Therapeutics, PMC Enter $60M Vaccines Deal

New Osteoporosis Research Finds Critical Bone Gene

Objectors Say Public Voice Weighted To Favor GMOs

Genetic Mutations Multiply To 'Incredibly' High Level

Epidauros, Parexel Enter Pharmacogenomics Deal

Biovector Launches IPO To Fund Growing Research

Pharming Reports Producing Transgenic Female Calves

NTB Raises C$3M To Fuel Nervous-System Research

U.K. Boosting Biotech With Four-Year Program

Germany's Chemical Industry Explores Uses Of DNA Chips

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...